Magnhild Sandberg Wollheim

21 – 30 of 38

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/d5c2bb47-eabf-4dc8-a65f-e729ee77059f?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2005
Mark Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis The EVIDENCE study.
Sandberg Wollheim, Magnhild ^LU ; Bever, C ; Carter, J ; Färkkilä, M ; Hurwitz, B ; Lapierre, Y ; Chang, P and Francis, G S (2005) In Journal of Neurology 252(1). p.41499-41499
- Contribution to journal › Article
Mark Predicting the Outcome of Optic Neuritis Evaluation of risk factors after 30 years of follow-up.
Nilsson, P ; Larsson, Elna-Marie ^LU ; Maly-Sundgren, P ; Perfekt, Roland ^LU and Sandberg Wollheim, Magnhild ^LU (2005) In Journal of Neurology 252(4). p.396-402
- Contribution to journal › Article
Mark Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
Polman, C ; Barkhof, F ; Sandberg Wollheim, Magnhild ^LU ; Linde, A ; Nordle, O and Nederman, T (2005) In Neurology 64(6). p.987-991
- Contribution to journal › Article
Mark Neutralizing antibodies and efficacy of interferon beta-1a - A 4-year controlled study
Kappos, L ; Clanet, M ; Sandberg Wollheim, Magnhild ^LU ; Radue, EW ; Hartung, HP ; Hohlfeld, R ; Xu, J ; Bennett, D ; Sandrock, A and Goelz, S (2005) In Neurology 65(1). p.40-47
- Contribution to journal › Article
Mark Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
Sandberg Wollheim, Magnhild ^LU ; Frank, D ; Goodwin, T M ; Giesser, B ; Lopez-Bresnahan, M ; Stam-Moraga, M ; Chang, P and Francis, G S (2005) In Neurology 65(6). p.802-806
- Contribution to journal › Article
2004
Mark No evidence for genetic linkage between development of multiple sclerosis and components of the IFN system and the JAK-STAT pathway.
Bergkvist, My ^LU ; Olsson, M and Sandberg Wollheim, Magnhild ^LU (2004) In Multiple Sclerosis Journal 10(1). p.87-88
- Contribution to journal › Article
Mark Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
Harbo, HF ; Lie, BA ; Sawcer, S ; Celius, EG ; Dai, KZ ; Oturai, A ; Hillert, J ; Lorentzen, AR ; Laaksonen, M and Myhr, KM , et al. (2004) In Tissue Antigens 63(3). p.237-247
- Contribution to journal › Article
Mark Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.
Andersen, O ; Elovaara, I ; Färkkilä, M ; Hansen, H J ; Mellgren, S I ; Myhr, K-M ; Sandberg Wollheim, Magnhild ^LU and Soelberg Sørensen, P (2004) In Journal of Neurology, Neurosurgery and Psychiatry 75(5). p.706-710
- Contribution to journal › Article
2003
Mark Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
Harbo, HF ; Datta, P ; Oturai, A ; Ryder, LP ; Sawcer, S ; Setakis, E ; Akesson, E ; Celius, EG ; Modin, H and Sandberg Wollheim, Magnhild ^LU , et al. (2003) In Journal of Neuroimmunology 143(1-2). p.101-106
- Contribution to journal › Article
2002
Mark International consensus statement on the use of disease-modifying agents in multiple sclerosis
Freedman, MS ; Blumhardt, LD ; Brochet, B ; Comi, G ; Noseworthy, JH ; Sandberg Wollheim, Magnhild ^LU and Sorensen, PS (2002) In Multiple Sclerosis Journal 8(1). p.19-23
- Contribution to journal › Article